Modeling Reactivity to Biological Macromolecules with a Deep Multitask Network

[Image: see text] Most small-molecule drug candidates fail before entering the market, frequently because of unexpected toxicity. Often, toxicity is detected only late in drug development, because many types of toxicities, especially idiosyncratic adverse drug reactions (IADRs), are particularly har...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Tyler B., Dang, Na Le, Miller, Grover P., Swamidass, S. Joshua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2016
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999971/
https://www.ncbi.nlm.nih.gov/pubmed/27610414
http://dx.doi.org/10.1021/acscentsci.6b00162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999971/
https://www.ncbi.nlm.nih.gov/pubmed/27610414
http://dx.doi.org/10.1021/acscentsci.6b00162

Ejemplares similares